DK3057571T3 - Protonpumpehæmmer-pastasammensætninger - Google Patents

Protonpumpehæmmer-pastasammensætninger Download PDF

Info

Publication number
DK3057571T3
DK3057571T3 DK13783629.2T DK13783629T DK3057571T3 DK 3057571 T3 DK3057571 T3 DK 3057571T3 DK 13783629 T DK13783629 T DK 13783629T DK 3057571 T3 DK3057571 T3 DK 3057571T3
Authority
DK
Denmark
Prior art keywords
ppi
paste
subject
compositions
composition
Prior art date
Application number
DK13783629.2T
Other languages
English (en)
Inventor
Manish Umrethia
Andrew Hilian
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Application granted granted Critical
Publication of DK3057571T3 publication Critical patent/DK3057571T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (3)

1. Stabil pastasammensætning, der omfatter: i) 1 til 45 vægt-% omeprazol, ii) 0,05 til 0,1 vægt-% af et alkanolamin-baseomdannende middel og iii) 54,9 til 98,95 vægt-% af et mineraloliebaseret vehikel med en densitet på ca. 0,769 g/mL til ca. 0,915 g/mL ved 15 °C målt ifølge ASTM D-1298 til anvendelse i behandling eller forebyggelse af mavesår hos et individ, hvori pastasammensætningen (a) er uden fortykkelsesmiddel og (b) administreres direkte som en oral farmaceutisk formulering til individet.
2. Sammensætning ifølge krav 1, hvori det alkanolaminbaseomdannende middel er monoethanolamin.
3. Sammensætning ifølge krav 1, hvori det mineraloliebaserede vehikel er flydende paraffin.
DK13783629.2T 2013-10-18 2013-10-18 Protonpumpehæmmer-pastasammensætninger DK3057571T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2013/052730 WO2015055974A1 (en) 2013-10-18 2013-10-18 Proton pump inhibitor paste compositions

Publications (1)

Publication Number Publication Date
DK3057571T3 true DK3057571T3 (da) 2019-04-15

Family

ID=49510431

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13783629.2T DK3057571T3 (da) 2013-10-18 2013-10-18 Protonpumpehæmmer-pastasammensætninger

Country Status (5)

Country Link
EP (1) EP3057571B1 (da)
DK (1) DK3057571T3 (da)
ES (1) ES2717029T3 (da)
PL (1) PL3057571T3 (da)
WO (1) WO2015055974A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018031935A1 (en) 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
EP3299017A1 (en) * 2016-09-23 2018-03-28 The Boots Company PLC Formulation
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004683B1 (ru) * 1999-02-23 2004-06-24 Мерк Энд Ко., Инк. Фармацевтическая композиция, содержащая омепразол
TWI232761B (en) * 2000-07-01 2005-05-21 Pharmaceutical Ind Tech & Dev Capsule preparation for oral administration and the preparation method thereof
WO2005000269A1 (en) * 2003-06-26 2005-01-06 Cipla Limited Pharmaceutical formulations comprising a proton pump inhibitor

Also Published As

Publication number Publication date
EP3057571B1 (en) 2019-03-06
EP3057571A1 (en) 2016-08-24
ES2717029T3 (es) 2019-06-18
PL3057571T3 (pl) 2019-07-31
WO2015055974A1 (en) 2015-04-23

Similar Documents

Publication Publication Date Title
HU230300B1 (hu) Prosztaglandin E1 helyi beadásra alkalmas készítmények
EA026456B1 (ru) Фармацевтическая композиция на основе антагониста crth2 и ингибитора протонного насоса для лечения эозинофильного эзофагита
US20230144845A1 (en) Alpha-Ketobutyrate, 2-Hydroxybutyrate, and Alpha-Ketoglutarate for Stimulating Hair Growth
JP2011144168A (ja) 非腸溶性酸不安定性薬物の液体剤形
DK3057571T3 (da) Protonpumpehæmmer-pastasammensætninger
CN110996949A (zh) 用于治疗行为改变的方法
JP2010138170A (ja) 抗疲労組成物
JP2012533633A (ja) 経口投与のための安定な薬学的オメプラゾール製剤
WO2014135956A1 (en) Composition for use in the treatment of polycystic ovary syndrome
KR102419769B1 (ko) 약물 조성물
JP6178802B2 (ja) 運動ニューロンのオートファジーを阻害するための医薬組成物およびその使用
Stoskopf et al. Pharmaceuticals and formularies
US8729026B2 (en) Method for inhibiting autophagy of motor neurons
JP2024519342A (ja) 自己免疫性、同種免疫性、炎症性、及びミトコンドリア性の状態を治療するための組成物、ならびにその使用
CN104706636A (zh) 一种阿苯达唑制剂及制备方法
GB2524351A (en) Proton Pump Inhibitor Paste Compositions
KR20220126426A (ko) 안정성이 향상된 라베프라졸을 유효성분으로 포함하는 경구용 속방형 제제 및 이의 제조방법
TW200400826A (en) Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of GERD
WO2019197564A1 (en) Mcoppb for use as medicament
JP6370634B2 (ja) 男性不妊症の予防乃至治療薬、及び食品乃至飼料
FR3069434A1 (fr) Acide anthranilique dans le traitement de l'atrophie musculaire
US20230285344A1 (en) SPECIALIZED PRO-RESOLVING MEDIATORS (SPMs) AS MELANOCYTE GROWTH PROMOTER AND PRO-SURVIVAL FACTORS AND USES THEREOF
JP2014001207A (ja) 解熱鎮痛薬組成物
KR20230137374A (ko) 경로 조절제, 이를 갖는 약학 조성물, 이의 용도 및 이를 이용한 치료 방법
JP5734134B2 (ja) 抗疲労用医薬組成物